Severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019
CSTR:
Author:
Affiliation:

Clc Number:

R511

Fund Project:

Supported by National Major Project for Infectious Disease Control (2017ZX10304403-003).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been confirmed as the etiological pathogen of the coronavirus disease 2019 (COVID-19). SARS-CoV-2 is the seventh member of coronavirus family that can infect humans after the emergence of the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV). SARS-CoV-2 is a single-stranded, positive-sense RNA virus. Due to its strong infectiousness and the lack of immunity in humans, the epidemic of the COVID-19 is still spreading. On January 30, 2020 (local time), the World Health Organization (WHO) defined the epidemics of SARS-CoV-2-infected pneumonia as a Public Health Emergency of International Concern (PHEIC). This paper reviews the etiology and pathogenicity of SARS-CoV-2, and the detection and diagnosis, prevention and control, as well as the treatment of COVID-19.

    Reference
    Related
    Cited by
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:February 07,2020
  • Revised:February 13,2020
  • Adopted:February 17,2020
  • Online: March 11,2020
  • Published:
Article QR Code